The Covid-19 pandemic’s impact on pharma and medical packaging solutions
In the ongoing Covid-19 pandemic, readiness to respond fast and industry expertise have become paramount in making healthcare products available. The DS Smith Pharma Business Unit and a worldwide network of designers can help deliver faster innovative and sustainable packaging solutions to the healthcare industry, through both the traditional or e-commerce distribution channels.
Speed is key
Fast project development has been a game changer during the pandemic. Our packaging designers across DS Smith’s markets have been requested to provide crucial support in an accelerated mode. Among the different projects, we can find the development of urgent packaging concepts for life-saving products such as vaccines, diagnostics and hospital medical devices.
Additionally, due to the current limitations for physical interactions, we have created virtual collaboration solutions for an unrivalled customer experience. DS Smith’s virtual tools ensure effective collaboration while physical meetings are not possible. Our designers have collaborated intensely with customers via live design sessions and virtual exchange platforms, using latest software systems (3D CAD, etc.) to create packaging concepts and designs and share instant feedback.
Centralized pharma and medical expertise
In hectic times like these, deep knowledge of the healthcare industry requirements is critical for fast project delivery. DS Smith has long responded to this need by creating a pharmaceutical and medical business unit to leverage expertise and manage projects globally. The company’s pharma experts bring innovative solutions to customers with focus on optimising resources, increasing productivity and reducing complexity.
The business unit as a key point of contact has proved successful during these last months. DS Smith’s Pharma and Medical Business Unit has helped the industry customers to keep a clear picture about their deliveries across several countries and coordinating backups if needed.
Sustainability and innovation at the heart of design
Focus on vaccines
Currently there are about 250 Covid-19 vaccines in development. Once launched, they will have to be swiftly delivered worldwide into different climate zones.
Focus on medical devices
Ventilators used in ICU wards proved to be decisive in saving lives during the first wave of the pandemic and countries needed to rush to secure enough of them.